Establishing reference intervals for islet autoantibodies in Han Chinese type 1 diabetes

References

• Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med. 1986;314(21):1360–1368.
   PubMed Web of Science ®Google Scholar
• Chiang JL, Kirkman MS, Laffel LMB, Type 1 Diabetes Sourcebook Authors, et al. Type 1 diabetes through the life span: a position statement of the American diabetes association. Diabetes Care. 2014;37(7):2034–2054.
   PubMed Web of Science ®Google Scholar
• Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet. 2008;371(9626):1777–1782.
   PubMed Web of Science ®Google Scholar
• Vehik K, Hamman RF, Lezotte D, et al. Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth. Diabetes Care. 2007;30(3):503–509.
   PubMed Web of Science ®Google Scholar
• Patterson C, Guariguata L, Dahlquist G, et al. Diabetes in the young – a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract. 2014;103(2):161–175.
   PubMed Web of Science ®Google Scholar
• Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA Oncol. 2013;309:2473–2479.
   Google Scholar
• Insel RA, Dunne JL, Atkinson MA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the endocrine society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964–1974.
   PubMed Web of Science ®Google Scholar
• Maldonado M, Hampe CS, Gaur LK, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab. 2003;88(11):5090–5098.
   PubMed Web of Science ®Google Scholar
• Mulukutla SN, Acevedo-Calado M, Hampe CS, et al. Autoantibodies to the IA-2 extracellular domain refine the definition of "a+" subtypes of ketosis-prone diabetes. Diabetes Care. 2018;41(12):2637–2640.
   PubMed Web of Science ®Google Scholar
• Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383(9911):69–82.
   PubMed Web of Science ®Google Scholar
• Schlosser M, Mueller PW, Torn C, Participating Laboratories, et al. Diabetes antibody standardization program: evaluation of assays for insulin autoantibodies. Diabetologia. 2010;53(12):2611–2620.
   PubMed Web of Science ®Google Scholar
• Bonifacio E, Yu L, Williams AK, et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. J Clin Endocrinol Metab. 2010;95(7):3360–3367.
   PubMed Web of Science ®Google Scholar
• Gu Y, Zhao Z, High H, et al. Islet autoantibody detection by electrochemiluminescence (ECL) assay. J Clin Cell Immunol. 2017;08(06):1000531.
   Google Scholar
• Liu Y, Li J, Wu J, et al. A plasmon-enhanced fluorescence protein microchip with high-sensitivity for multiple islet autoantibodies measurements in autoimmune diabetes diagnosis. J Biomed Nanotechnol. 2018;14(8):1496–1504.
   PubMedGoogle Scholar
• Kikkas I, Mallone R, Larger E, et al. A rapid lateral flow immunoassay for the detection of tyrosine phosphatase-like protein IA-2 autoantibodies in human serum. PLoS One. 2014;9(7):e103088.
   PubMed Web of Science ®Google Scholar
• Amoroso M, Achenbach P, Powell M, et al. 3 Screen islet cell autoantibody ELISA: a sensitive and specific ELISA for the combined measurement of autoantibodies to GAD65, to IA-2 and to ZnT8. Clin Chim Acta. 2016;462:60–64.
   PubMed Web of Science ®Google Scholar
• Kawasaki E, Tanaka M, Miwa M, et al. Novel enzyme-linked immunosorbent assay for bivalent ZnT8 autoantibodies. Acta Diabetol. 2014;51(3):429–434.
   PubMed Web of Science ®Google Scholar
• Miller WG, Horowitz GL, Ceriotti F, et al. Reference intervals: strengths, weaknesses, and challenges. Clin Chem. 2016;62(7):916–923.
   PubMed Web of Science ®Google Scholar
• Sickle DV, Chertow D. Inappropriate reference intervals for carboxyhemoglobin at some Florida hospitals. Clin Chem. 2006;52(2):338.
   PubMed Web of Science ®Google Scholar
• Weng J, Zhou Z, Guo L, et al. Incidence of type 1 diabetes in China, 2010–13: population based study. BMJ. 2018;360:j5295.
   PubMedGoogle Scholar
• Horowitz GL, Altaie S, Boyd JC, et al. Defining, establishing, and verifying reference intervals in the clinical laboratory. Wayne, PA: CLSI, 2010.
   Google Scholar
• Gu Y, Zhang M, Chen H, et al. Discordant association of islet autoantibodies with high-risk HLA genes in Chinese type 1 diabetes. Diabetes Metab Res Rev. 2011;27(8):899–905.
   PubMed Web of Science ®Google Scholar
• Dixon WJ. Processing data for outliers. Biometrics. 1953;9(1):74–89.
   Web of Science ®Google Scholar
• Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test results: is there a better way? Am J Clin Pathol. 2010;133(2):180–186.
   PubMed Web of Science ®Google Scholar
• Wyatt R, Williams AJ. Islet autoantibody analysis: radioimmunoassays. Methods Mol Biol. 2016;1433:57–83.
   PubMedGoogle Scholar
• Verge CF, Stenger D, Bonifacio E, et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: combinatorial islet autoantibody workshop. Diabetes. 1998;47(12):1857–1866.
   PubMed Web of Science ®Google Scholar
• Gu Y, Zhao Z, Waugh K, et al. High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneously. EBioMedicine. 2019;47:365–372.
   PubMed Web of Science ®Google Scholar
• Torn C, Mueller PW, Schlosser M, Participating Laboratories, et al. Diabetes antibody standardization program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia. 2008;51(5):846–852.
   PubMed Web of Science ®Google Scholar
• Ritchie RF, Palomaki G. Selecting clinically relevant populations for reference intervals. Clin Chem Lab Med. 2004;42(7):702–709.
   PubMed Web of Science ®Google Scholar
• Yang J, Tang A, Ma J, et al. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1. Scand J Clin Lab Invest. 2019;79(1–2):71–74.
   PubMed Web of Science ®Google Scholar
• Wang D, Yu S, Ma C, et al. Reference intervals for thyroid-stimulating hormone, free thyroxine, and free triiodothyronine in elderly Chinese persons. Clin Chem Lab Med. 2019;57(7):1044–1052.
   PubMed Web of Science ®Google Scholar
• Kjaer IM, Olsen DA, Alnor A, et al. EGFR and EGFR ligands in serum in healthy women; reference intervals and age dependency. Clin Chem Lab Med. 2019;57(12):1948–1955.
   PubMed Web of Science ®Google Scholar
• Bohn MK, Higgins V, Asgari S, et al. Paediatric reference intervals for 17 Roche cobas 8000 e602 immunoassays in the CALIPER cohort of healthy children and adolescents. Clin Chem Lab Med. 2019;57(12):1968–1979.
   PubMed Web of Science ®Google Scholar
• La'ulu SL, Roberts WL. Ethnic differences in first-trimester thyroid reference intervals. Clin Chem. 2011;57(6):913–915.
   PubMed Web of Science ®Google Scholar
• Lim E, Miyamura J, Chen J. Racial/ethnic-specific reference intervals for common laboratory tests: a comparison among Asians, blacks, Hispanics, and white. Hawaii J Med Public Health. 2015;74(9):302–310.
   PubMedGoogle Scholar